News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,175 Results
Type
Article (64)
Press Release (1111)
Section
Business (257)
Deals (49)
Drug Development (363)
FDA (45)
Job Trends (32)
News (696)
Policy (65)
Tag
Academia (1)
Alliances (57)
Approvals (44)
Automation (1)
Bankruptcy (1)
Best Places to Work (28)
Cancer (2)
Clinical research (344)
Collaboration (3)
COVID-19 (5)
Data (6)
Diabetes (7)
Diagnostics (4)
Earnings (137)
Events (186)
Executive appointments (1)
FDA (48)
Funding (1)
Gene therapy (1)
GLP-1 (3)
Government (8)
Healthcare (5)
Indications (1)
Infectious disease (5)
Inflammatory bowel disease (1)
IPO (27)
Job creations (2)
Layoffs (3)
Legal (4)
Manufacturing (1)
Medical device (7)
Medtech (7)
Mergers & acquisitions (23)
Metabolic disorders (8)
Neurodegenerative disease (1)
Neuroscience (2)
NextGen: Class of 2026 (5)
Non-profit (1)
Obesity (1)
Parkinson's disease (2)
Patents (1)
Patient recruitment (1)
People (50)
Phase 1 (51)
Phase 2 (145)
Phase 3 (168)
Pipeline (5)
Postmarket research (15)
Preclinical (11)
Radiopharmaceuticals (1)
Rare diseases (2)
Real estate (3)
Regulatory (63)
Research institute (2)
Startups (11)
Weight loss (1)
Date
Last 7 days (2)
Last 30 days (4)
Last 365 days (36)
2026 (5)
2025 (33)
2024 (52)
2023 (56)
2022 (51)
2021 (57)
2020 (74)
2019 (78)
2018 (62)
2017 (83)
2016 (65)
2015 (81)
2014 (60)
2013 (37)
2012 (48)
2011 (49)
2010 (48)
Location
Africa (1)
Asia (55)
Australia (5)
California (8)
Canada (15)
China (1)
Europe (243)
Florida (1)
Maryland (1)
Massachusetts (11)
Michigan (1)
New Jersey (2)
New York (2)
North Carolina (15)
Northern California (5)
Southern California (2)
United States (41)
1,175 Results for "ttp ventus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NeuraLight and Teitur Trophics Announce Collaboration to Use Precision Biomarkers in TT-P34 Parkinson’s Disease Clinical Trial
January 22, 2026
·
3 min read
Press Releases
Ventus Therapeutics Enters into a Collaboration and License Agreement with Genentech to Discover and Develop Small-Molecule Medicines Using Ventus’ ReSOLVE® Platform
October 22, 2025
·
3 min read
Press Releases
Ventus Therapeutics Announces Nomination of VENT-04, a First-in-Class, Oral, Small-Molecule Caspase-4/5 Inhibitor, as a Development Candidate
January 8, 2026
·
3 min read
Press Releases
Ventus Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of VENT-03, a Novel Small Molecule cGAS Inhibitor, in Patients with Lupus
December 11, 2025
·
4 min read
Press Releases
Ventus Therapeutics to Present at Morgan Stanley 23rd Annual Global Healthcare Conference
September 5, 2025
·
1 min read
Press Releases
Ventus Therapeutics to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference
April 29, 2025
·
1 min read
Press Releases
Ventus Therapeutics to Present Phase 1 Results for VENT-03, a First-in-Class cGAS Inhibitor, at LUPUS 2025
May 22, 2025
·
4 min read
Press Releases
Ventus Therapeutics Appoints Mona Kotecha, M.D., as Chief Medical Officer
February 19, 2025
·
2 min read
Business
Cellular Origins, a TTP Company, Appoints Peter Crossley as Chief Operating Officer
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies, announced the appointment of Peter Crossley as Chief Operating Officer.
January 25, 2024
·
2 min read
Genetown
Ventus Therapeutics to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Ventus Therapeutics, Inc announced today that its President and Chief Executive Officer, Marcelo Bigal, M.D., Ph.D., will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference.
April 8, 2024
·
2 min read
1 of 118
Next
